DE69629618D1 - Behandlung von motorischen Fehlfunktionen - Google Patents

Behandlung von motorischen Fehlfunktionen

Info

Publication number
DE69629618D1
DE69629618D1 DE69629618T DE69629618T DE69629618D1 DE 69629618 D1 DE69629618 D1 DE 69629618D1 DE 69629618 T DE69629618 T DE 69629618T DE 69629618 T DE69629618 T DE 69629618T DE 69629618 D1 DE69629618 D1 DE 69629618D1
Authority
DE
Germany
Prior art keywords
treatment
motor malfunctions
methyl
malfunctions
motor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69629618T
Other languages
English (en)
Other versions
DE69629618T2 (de
Inventor
Beasley, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69629618D1 publication Critical patent/DE69629618D1/de
Publication of DE69629618T2 publication Critical patent/DE69629618T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Saccharide Compounds (AREA)
DE69629618T 1995-04-21 1996-04-18 Behandlung von motorischen Fehlfunktionen Expired - Fee Related DE69629618T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US422177 1989-10-13
US08/422,177 US5776928A (en) 1995-04-21 1995-04-21 Method for treating dyskinesias with olanzapine

Publications (2)

Publication Number Publication Date
DE69629618D1 true DE69629618D1 (de) 2003-10-02
DE69629618T2 DE69629618T2 (de) 2004-06-17

Family

ID=23673720

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629618T Expired - Fee Related DE69629618T2 (de) 1995-04-21 1996-04-18 Behandlung von motorischen Fehlfunktionen

Country Status (11)

Country Link
US (1) US5776928A (de)
EP (1) EP0738514B1 (de)
JP (1) JPH11504014A (de)
AT (1) ATE247966T1 (de)
AU (1) AU5555596A (de)
CA (1) CA2218062A1 (de)
DE (1) DE69629618T2 (de)
ES (1) ES2206544T3 (de)
IL (1) IL117971A (de)
WO (1) WO1996032948A1 (de)
ZA (1) ZA963098B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7013196A (en) * 1995-09-29 1997-04-17 Eli Lilly And Company Method for treating a tic disorder
CN1239158C (zh) * 1997-09-30 2006-02-01 伊莱利利公司 2－甲基－噻吩并－苯并二氮杂䓬制剂
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20050153954A1 (en) * 2002-04-23 2005-07-14 Reguri Buchi R. Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
SI21270A (sl) * 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2006073886A1 (en) * 2005-01-05 2006-07-13 Eli Lilly And Company Olanzapine pamoate dihydrate
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
WO1996032948A1 (en) 1996-10-24
DE69629618T2 (de) 2004-06-17
IL117971A (en) 1999-12-31
JPH11504014A (ja) 1999-04-06
US5776928A (en) 1998-07-07
ATE247966T1 (de) 2003-09-15
ES2206544T3 (es) 2004-05-16
EP0738514B1 (de) 2003-08-27
ZA963098B (en) 1997-10-20
AU5555596A (en) 1996-11-07
IL117971A0 (en) 1996-08-04
EP0738514A1 (de) 1996-10-23
CA2218062A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
DE69629618D1 (de) Behandlung von motorischen Fehlfunktionen
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
DK1438957T3 (da) Raloxifen til behandling af postmenopausal osteoporose
NL1003300A1 (nl) Implanteerbare therapeutische inrichting.
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
AU5802196A (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
HUP9802677A3 (en) Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
ZA971600B (en) Treatment of macular edema.
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
AU6147296A (en) Therapeutic use of acetazolamide for the treatment of brain edema
ZA964198B (en) Treatment regime for skin.
NO974766L (no) Fremgangsmåte for behandling av dysfunksjon
DK0831835T3 (da) Behandling af anorexia
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
ZA9610761B (en) Medical treatment.
NO984198L (no) FremgangsmÕte for behandling av aggresjon
EP0872239A3 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
RU95119984A (ru) Способ лечения тяжелой сочетанной травмы
ES1030216Y (es) Cinturon terapeutico para el tratamiento de la impotencia.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee